|
Volumn 33, Issue 7-8, 2001, Pages 3334-3336
|
Induction versus noninduction protocols in anti-calcineurin-based immunosuppression
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
CALCINEURIN;
CORTICOSTEROID;
CYCLOSPORIN;
GANCICLOVIR;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
TACROLIMUS;
CREATININE;
LYMPHOCYTE ANTIBODY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT REJECTION;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
LONG TERM EXPOSURE;
LYMPHOCYTE FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEPHROTOXICITY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
T LYMPHOCYTE;
BLOOD;
CLASSIFICATION;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
GRAFT REJECTION;
IMMUNOLOGY;
METHODOLOGY;
PHYSIOLOGY;
POSTOPERATIVE COMPLICATION;
SAFETY;
ADRENAL CORTEX HORMONES;
ANTILYMPHOCYTE SERUM;
CALCINEURIN;
CREATININE;
DRUG ADMINISTRATION SCHEDULE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
SAFETY;
TACROLIMUS;
|
EID: 0035542962
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02435-6 Document Type: Article |
Times cited : (7)
|
References (2)
|